CD1B Activators are a diverse set of chemical compounds that enhance the functional activity of CD1B through various cellular mechanisms. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Ionophore A23187 directly activate signaling pathways that promote the trafficking and expression of CD1B. PMA, by mimicking diacylglycerol, activates PKC leading to the enhanced surface expression of CD1B, crucial for its role in presenting lipid antigens to T-cells. Similarly, A23187 increases intracellular calcium levels, a key factor for the trafficking and recycling of CD1B molecules, thus potentiating its antigen-presenting capabilities. Brefeldin A and Monensin, by manipulating intracellular transport and pH respectively, lead to the accumulation of CD1B within cells and its subsequent enhanced presentation activity. Retinoic acid and Pioglitazone act by influencing dendritic cell differentiation and lipid metabolism, leading to upregulated expression of CD1B and modification of the lipid antigen repertoire available for CD1B-mediated presentation. Curcumin, through its immunomodulatory effects, potentially enhances CD1B activity by altering lipid antigen pools.
Additionally, specific glycolipids, including synthetic ones and α-Galactosylceramide, directly interact with CD1B, facilitating its function in antigen presentationto natural killer T cells, thereby enhancing the immune response. Lipopolysaccharide (LPS) acts as an adjuvant that stimulates the innate immune system, which in turn enhances the expression of CD1B on antigen-presenting cells, optimizing its antigen-presenting function. Cholesterol, being a fundamental component of cellular membranes, plays a role in modulating the membrane environment of CD1B, potentially increasing its stability and the efficiency of antigen presentation. Ceramide, known for its ability to influence membrane microdomains, may enhance the clustering of CD1B, thereby augmenting its ability to present lipid antigens effectively. These CD1B Activators collectively function to enhance the role of CD1B in the immune response without the need for direct activation or upregulation of its expression, instead, they work by optimizing the cellular environment and signaling pathways that CD1B relies upon for its antigen-presenting activities.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol analog to activate protein kinase C (PKC), which can enhance the expression and function of CD1B by promoting its trafficking to the cell surface, where CD1B presents lipid antigens to T-cells. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the CD1B antigen presentation function as intracellular calcium flux is crucial for the trafficking and recycling of CD1B molecules. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, leading to the accumulation of CD1B in the cytoplasm, which may enhance its antigen-presenting function upon release. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that alters intracellular pH and ion concentrations, which can promote the trafficking of CD1B to the cell surface and enhance antigen presentation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence the differentiation of dendritic cells and upregulate the expression of CD1B, thus potentially enhancing its antigen-presenting activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, modulates lipid metabolism and may influence the lipid antigen repertoire presented by CD1B, indirectly enhancing its function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate lipid metabolism and has immunomodulatory effects that might enhance the function of CD1B by altering the pool of lipid antigens available for presentation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS can act as an adjuvant to stimulate the innate immune system, leading to upregulation of CD1B expression on antigen-presenting cells and enhancing its functional activity. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
Cholesterol is a component of cell membranes and can influence the membrane environment of CD1B, potentially enhancing its stability and function in antigen presentation. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can modulate membrane microdomains and affect the localization and clustering of CD1B, which may enhance its capacity to present lipid antigens. | ||||||